Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism

Molecules. 2020 Dec 22;26(1):5. doi: 10.3390/molecules26010005.

Abstract

Andrographolide is a labdane diterpene and the main active ingredient isolated from the herb Andrographis paniculata. Andrographolide possesses diverse biological effects including anti-inflammatory, antioxidant, and antineoplastic properties. Clinical studies have demonstrated that andrographolide could be useful in therapy for a wide range of diseases such as osteoarthritis, upper respiratory diseases, and multiple sclerosis. Several targets are described for andrographolide, including the interference of transcription factors NF-κB, AP-1, and HIF-1 and signaling pathways such as PI3K/Akt, MAPK, and JAK/STAT. In addition, an increase in the Nrf2 (nuclear factor erythroid 2-related factor 2) signaling pathway also supports its antioxidant and anti-inflammatory properties. However, this scenario could be more complex since recent evidence suggests that andrographolide targets can modulate glucose metabolism. The metabolic effect of andrographolide might be the key to explaining the diverse therapeutic effects described in preclinical and clinical studies. This review discusses some of the most recent evidence about the anti-inflammatory and metabolic effects of andrographolide.

Keywords: andrographolide; anti-inflammatory; glycolysis; metabolism; multitarget.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacokinetics*
  • Biomarkers
  • Diterpenes / chemistry
  • Diterpenes / pharmacokinetics*
  • Humans
  • Metabolic Networks and Pathways / drug effects
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacokinetics
  • Signal Transduction / drug effects
  • Tissue Distribution

Substances

  • Anti-Inflammatory Agents
  • Biomarkers
  • Diterpenes
  • Plant Extracts
  • andrographolide